Clinical Magnet Application to Temporarily Inhibit Subcutaneous
Implantable Cardioverter Defibrillators Therapy in Emergency Situations:
One size fits all.
Abstract
The subcutaneous implantable cardioverter defibrillatoruse has increased
worldwide. The annual rate of inappropriate shock (IAS) is between 3.1%
and 25% and is usually followed by admission in Critical Care units. In
such setting, the suspension of shock therapy is mandatory during an
electrical storm. Temporary inhibition is also requested during surgical
procedures but now is not yet clearly addressed by guidelines. Here we
describe the strategies that can be followed to reduce IAS in critical
care settings with the appropriate use of any model of clinical magnet,
to temporarily inhibit shock therapies.